URGN Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 5.10%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $231,431.84

UroGen Pharma Insider Trading History Chart

UroGen Pharma Share Price & Price History

^$11.20

▼ -0.25 (-2.18%)

As of 03/28/2025 05:00 PM ET

Days: 30 | 90 | 365

UroGen Pharma Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
1/31/2025	Jason Drew Smith	General Counsel	Sell	7,379	$11.14	$82,202.06	26,468
1/31/2025	Mark Schoenberg	Insider	Sell	4,551	$11.14	$50,698.14	145,666
9/9/2024	Jason Drew Smith	General Counsel	Sell	1,521	$13.08	$19,894.68	25,226
9/9/2024	Mark Schoenberg	Insider	Sell	859	$13.08	$11,235.72	145,091
6/10/2024	Mark Schoenberg	Insider	Sell	5,153	$13.08	$67,401.24	144,284
3/18/2024	Mark Schoenberg	Insider	Sell	12,000	$14.05	$168,600.00	139,437
1/31/2024	Jason Drew Smith	General Counsel	Sell	4,993	$15.74	$78,589.82	18,824
1/31/2024	Mark Schoenberg	Insider	Sell	3,789	$15.74	$59,638.86	149,423
8/31/2023	Jason Drew Smith	General Counsel	Sell	3,800	$18.01	$68,438.00	18,407
1/31/2023	Jason Drew Smith	General Counsel	Sell	1,636	$10.12	$16,556.32	12,600
1/31/2023	Mark Schoenberg	Insider	Sell	1,900	$10.12	$19,228.00	146,879
10/31/2022	Mark Schoenberg	Insider	Sell	258	$11.85	$3,057.30	23,950
8/1/2022	Mark Schoenberg	Insider	Sell	259	$7.81	$2,022.79	23,708
4/30/2022	Mark Schoenberg	Insider	Sell	254	$6.62	$1,681.48	23,467

See Full Table

SEC Filings (Institutional Ownership Changes) for UroGen Pharma (NASDAQ:URGN)

91.29% of UroGen Pharma stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

UroGen Pharma Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
3/24/2025	Wellington Management Group LLP	146,953	$1.57M	0.0%	+7.0%	0.319%
2/19/2025	Toronto Dominion Bank	1,749,142	$18.63M	0.0%	N/A	7.459%
2/17/2025	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	1,377,156	$14.67M	0.0%	+2.7%	5.873%
2/17/2025	Vestal Point Capital LP	1,630,000	$17.36M	1.0%	+307.5%	6.951%
2/17/2025	Squarepoint Ops LLC	50,194	$0.54M	0.0%	-53.4%	0.214%
2/17/2025	Two Sigma Investments LP	56,895	$0.61M	0.0%	-34.6%	0.243%
2/17/2025	Tidal Investments LLC	30,526	$0.33M	0.0%	-18.8%	0.130%
2/17/2025	Stonepine Capital Management LLC	324,324	$3.45M	2.8%	+15.7%	1.383%
2/17/2025	Toronto Dominion Bank	1,749,142	$18.63M	0.0%	N/A	7.459%
2/17/2025	RTW Investments LP	3,834,794	$40.84M	0.6%	+1.3%	16.353%
2/17/2025	Point72 Asset Management L.P.	317,114	$3.38M	0.0%	-79.0%	1.352%
2/17/2025	ProShare Advisors LLC	12,895	$0.14M	0.0%	N/A	0.055%
2/17/2025	Parkman Healthcare Partners LLC	369,861	$3.94M	0.5%	+6.4%	1.577%
2/17/2025	Nuveen Asset Management LLC	92,957	$0.99M	0.0%	-37.8%	0.396%
2/17/2025	Millennium Management LLC	645,785	$6.88M	0.0%	-56.9%	2.754%
2/17/2025	MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.	21,667	$0.23M	0.0%	+4.7%	0.092%
2/17/2025	Lazard Asset Management LLC	6,364	$67K	0.0%	N/A	0.027%
2/17/2025	Janus Henderson Group PLC	14,000	$0.15M	0.0%	N/A	0.060%
2/17/2025	Jefferies Financial Group Inc.	965,929	$10.29M	0.1%	+0.1%	4.119%
2/17/2025	Hudson Bay Capital Management LP	233,322	$2.49M	0.0%	N/A	0.995%
2/17/2025	Coastal Bridge Advisors LLC	39,000	$0.42M	0.1%	-3.7%	0.166%
2/17/2025	Deutsche Bank AG	31,263	$0.33M	0.0%	+61.6%	0.133%
2/17/2025	DAFNA Capital Management LLC	492,515	$5.25M	1.3%	+7.3%	2.100%
2/17/2025	Corton Capital Inc.	13,861	$0.15M	0.1%	-11.7%	0.059%
2/17/2025	Cantor Fitzgerald L. P.	360,000	$3.79M	0.1%	N/A	1.535%
2/17/2025	Balyasny Asset Management L.P.	24,481	$0.26M	0.0%	-14.4%	0.104%
2/17/2025	Bank of America Corp DE	72,472	$0.77M	0.0%	+9.0%	0.309%
2/17/2025	BNP Paribas Financial Markets	4,801	$51K	0.0%	-43.8%	0.020%
2/17/2025	Ameriprise Financial Inc.	49,153	$0.52M	0.0%	+9.3%	0.210%
2/17/2025	Acorn Capital Advisors LLC	1,516,303	$16.15M	8.8%	N/A	6.466%
2/14/2025	Jane Street Group LLC	26,338	$0.28M	0.0%	-14.3%	0.112%
2/14/2025	Schonfeld Strategic Advisors LLC	68,100	$0.73M	0.0%	-45.2%	0.290%
2/14/2025	Nantahala Capital Management LLC	1,371,638	$14.61M	0.6%	N/A	5.849%
2/14/2025	Northern Trust Corp	310,074	$3.30M	0.0%	+8.1%	1.322%
2/14/2025	The Manufacturers Life Insurance Company	37,486	$0.40M	0.0%	+178.1%	0.160%
2/14/2025	Aquatic Capital Management LLC	9,446	$0.10M	0.0%	N/A	0.040%
2/14/2025	Susquehanna Fundamental Investments LLC	19,541	$0.21M	0.0%	N/A	0.083%
2/14/2025	Adage Capital Partners GP L.L.C.	2,928,086	$31.18M	0.1%	-21.6%	12.487%
2/14/2025	Price T Rowe Associates Inc. MD	393,984	$4.20M	0.0%	+2,968.7%	1.680%
2/14/2025	Silverarc Capital Management LLC	1,120,473	$11.93M	2.6%	+24.3%	4.778%
2/14/2025	Diadema Partners LP	50,000	$0.53M	0.2%	N/A	0.213%
2/14/2025	MetLife Investment Management LLC	22,766	$0.24M	0.0%	+13.6%	0.097%
2/14/2025	Epoch Investment Partners Inc.	125,688	$1.34M	0.0%	-8.2%	0.536%
2/13/2025	Marshall Wace LLP	136,491	$1.45M	0.0%	N/A	0.582%
2/13/2025	Jump Financial LLC	17,185	$0.18M	0.0%	-69.6%	0.073%
2/13/2025	XTX Topco Ltd	18,641	$0.20M	0.0%	-20.3%	0.079%
2/13/2025	Barclays PLC	69,325	$0.74M	0.0%	+16.0%	0.296%
2/13/2025	Renaissance Technologies LLC	138,200	$1.47M	0.0%	N/A	0.589%
2/13/2025	Legal & General Group Plc	19,845	$0.21M	0.0%	+24.6%	0.085%
2/13/2025	Wells Fargo & Company MN	221,540	$2.36M	0.0%	+2.7%	0.945%
2/12/2025	ExodusPoint Capital Management LP	33,598	$0.36M	0.0%	N/A	0.143%
2/12/2025	Trexquant Investment LP	172,551	$1.84M	0.0%	-36.5%	0.736%
2/12/2025	Geode Capital Management LLC	461,902	$4.92M	0.0%	+1.4%	1.970%
2/12/2025	Alliancebernstein L.P.	199,259	$2.12M	0.0%	+751.5%	0.850%
2/12/2025	Wellington Management Group LLP	146,953	$1.57M	0.0%	+7.0%	0.627%
2/12/2025	JPMorgan Chase & Co.	21,114	$0.23M	0.0%	-69.0%	0.090%
2/11/2025	Corebridge Financial Inc.	19,237	$0.21M	0.0%	-4.9%	0.082%
2/11/2025	KLP Kapitalforvaltning AS	5,500	$59K	0.0%	N/A	0.023%
2/11/2025	Rosalind Advisors Inc.	870,000	$9.27M	4.6%	N/A	3.710%
2/11/2025	Privium Fund Management B.V.	27,691	$0.30M	0.1%	N/A	0.118%
2/7/2025	Bender Robert & Associates	34,701	$0.37M	0.1%	N/A	0.148%
2/6/2025	Charles Schwab Investment Management Inc.	93,517	$1M	0.0%	+3.3%	0.399%
2/5/2025	Oppenheimer & Co. Inc.	11,875	$0.13M	0.0%	N/A	0.051%
2/4/2025	ARK Investment Management LLC	140,148	$1.49M	0.0%	+15.2%	0.598%
2/4/2025	Bank of New York Mellon Corp	93,997	$1M	0.0%	+7.3%	0.401%
1/31/2025	Rice Hall James & Associates LLC	264,031	$2.81M	0.2%	-2.9%	1.126%
1/30/2025	Rhumbline Advisers	51,270	$0.55M	0.0%	+2.8%	0.219%
1/17/2025	SG Americas Securities LLC	20,269	$0.22M	0.0%	+44.1%	0.086%
1/15/2025	Oak Ridge Investments LLC	61,165	$0.65M	0.1%	-20.4%	0.261%
12/26/2024	JPMorgan Chase & Co.	68,062	$0.86M	0.0%	+263.1%	0.290%
11/25/2024	Tidal Investments LLC	37,595	$0.48M	0.0%	+19.1%	0.160%
11/19/2024	Barclays PLC	59,778	$0.76M	0.0%	+409.3%	0.255%
11/16/2024	Geode Capital Management LLC	455,637	$5.79M	0.0%	+8.1%	1.943%
11/15/2024	Barclays PLC	59,778	$0.76M	0.0%	+409.3%	0.255%
11/15/2024	XTX Topco Ltd	23,381	$0.30M	0.0%	N/A	0.100%
11/15/2024	Jane Street Group LLC	30,718	$0.39M	0.0%	-21.1%	0.131%
11/15/2024	Wellington Management Group LLP	137,300	$1.74M	0.0%	-12.0%	0.586%
11/15/2024	State Street Corp	769,583	$9.77M	0.0%	+5.9%	3.282%
11/15/2024	RTW Investments LP	3,787,347	$48.10M	0.7%	+6.5%	16.151%
11/15/2024	Point72 Asset Management L.P.	1,506,646	$19.13M	0.0%	-38.5%	6.425%
11/15/2024	Parkman Healthcare Partners LLC	347,541	$4.41M	0.6%	+26.6%	1.482%
11/15/2024	HighVista Strategies LLC	38,566	$0.49M	0.2%	N/A	0.164%
11/14/2024	Verition Fund Management LLC	13,254	$0.17M	0.0%	N/A	0.057%
11/14/2024	Vestal Point Capital LP	400,000	$5.08M	0.4%	N/A	1.705%
11/14/2024	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	1,341,072	$17.03M	0.0%	+1.6%	5.718%
11/14/2024	Stonepine Capital Management LLC	280,345	$3.56M	2.2%	N/A	1.195%
11/13/2024	Great Point Partners LLC	758,786	$9.64M	2.8%	-73.9%	3.235%
11/13/2024	BNP Paribas Financial Markets	8,546	$0.11M	0.0%	+221.8%	0.036%
11/13/2024	FMR LLC	23,090	$0.29M	0.0%	+575.1%	0.098%
11/12/2024	Charles Schwab Investment Management Inc.	90,493	$1.15M	0.0%	+9.1%	0.386%
11/9/2024	Intech Investment Management LLC	12,203	$0.16M	0.0%	N/A	0.052%
11/5/2024	GSA Capital Partners LLP	19,597	$0.25M	0.0%	N/A	0.084%
10/31/2024	ARK Investment Management LLC	121,634	$1.55M	0.0%	-19.9%	0.519%
10/28/2024	Oak Ridge Investments LLC	76,799	$0.98M	0.1%	-3.9%	0.327%
10/28/2024	Rice Hall James & Associates LLC	271,897	$3.45M	0.2%	+273.6%	1.159%
10/25/2024	China Universal Asset Management Co. Ltd.	8,100	$0.10M	0.0%	+90.9%	0.035%
10/11/2024	Wesbanco Bank Inc.	74,400	$0.95M	0.0%	N/A	0.317%
10/3/2024	SG Americas Securities LLC	14,062	$0.18M	0.0%	N/A	0.060%
8/16/2024	Coastal Bridge Advisors LLC	38,500	$0.65M	0.2%	+4.1%	0.164%
8/16/2024	Annandale Capital LLC	75,552	$1.27M	0.2%	-7.4%	0.322%

Data available starting January 2016

See Full Table

UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization of solutions for urothelial and specialty cancers. It offers RTGel, a novel proprietary polymeric biocompatible, reverse thermal gelation hydrogel technology to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead product candidate is UGN-102 for the treatment of several forms of non-muscle invasive urothelial cancer that include low-grade upper tract urothelial cancer and low-grade intermediate risk non-muscle invasive bladder cancer (NMIBC). It is also developing UGN-301 for the treatment of high-grade NMIBC. The company has license agreement with Agenus Inc. to develop, make, use, sell, import, and commercialize products of Agenus for the treatment of cancers of the urinary tract via intravesical delivery; strategic research collaboration agreement with MD Anderson focusing on the sequential use of UGN-201 and UGN-301 for the treatment of NMIBC; and licensing and supply agreement with medac Gesellschaft für klinische Spezialpräparate m.b.H. to develop UGN-103 in low-grade intermediate risk NMIBC and UGN-104 in low-grade upper tract urothelial carcinoma. UroGen Pharma Ltd. was incorporated in 2004 and is based in Princeton, New Jersey.

Today's Range

Now: $11.20

$11.05

$11.55

50 Day Range

MA: $10.66

$9.27

$12.13

52 Week Range

Now: $11.20

$9.03

$20.70

Volume

177,900 shs

Average Volume

500,644 shs

Market Capitalization

$516.25 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.12

Who are the company insiders with the largest holdings of UroGen Pharma?: UroGen Pharma's top insider investors include:
Mark Schoenberg (Insider)
Jason Drew Smith (General Counsel)
Learn More about top insider investors at UroGen Pharma.
Who are the major institutional investors of UroGen Pharma?: UroGen Pharma's top institutional investors include:
RTW Investments LP — 16.35%
Adage Capital Partners GP L.L.C. — 12.49%
Toronto Dominion Bank — 7.46%
Toronto Dominion Bank — 7.46%
Vestal Point Capital LP — 6.95%
Acorn Capital Advisors LLC — 6.47%
Learn More about top institutional investors of UroGen Pharma stock.
Which institutional investors are selling UroGen Pharma stock?: In the last quarter, URGN stock was sold by these institutional investors:
Point72 Asset Management L.P.
Millennium Management LLC
Adage Capital Partners GP L.L.C.
Trexquant Investment LP
Squarepoint Ops LLC
Nuveen Asset Management LLC
Schonfeld Strategic Advisors LLC
Citadel Advisors LLC
Within the previous year, company insiders that have sold UroGen Pharma company stock include:
Mark Schoenberg (Insider)
Jason Drew Smith (General Counsel)
Learn More investors selling UroGen Pharma stock.
Which institutional investors are buying UroGen Pharma stock?: Within the last quarter, URGN stock was purchased by institutional investors including:
Toronto Dominion Bank
Toronto Dominion Bank
Acorn Capital Advisors LLC
Nantahala Capital Management LLC
Vestal Point Capital LP
Rosalind Advisors Inc.
Price T Rowe Associates Inc. MD
Cantor Fitzgerald L. P.